Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model
NEW YORK (
) hit a new 52-week high Friday as it is currently trading at $41.43, above its previous 52-week high of $41.23 with 663,036 shares traded as of 11 a.m. ET. Average volume has been 2.6 million shares over the past 30 days.
AmerisourceBergen has a market cap of $10.28 billion and is part of the services sector and wholesale industry. Shares are up 9.8% year to date as of the close of trading on Wednesday.
AmerisourceBergen Corporation, a pharmaceutical services company, provides drug distribution and related services to healthcare providers and pharmaceutical manufacturers primarily in the United States and Canada. The company has a P/E ratio of 14.8, below the S&P 500 P/E ratio of 17.7.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
TheStreet Ratings rates AmerisourceBergen as a
. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, notable return on equity, good cash flow from operations, increase in net income and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows low profit margins. You can view the full
52-week high stocks
or get investment ideas from our
FREE for a limited time only: Get TheStreet Ratings #1 Stock Report NOW!